Literature DB >> 28495698

Pulmonary arterial hypertension: screening challenges in systemic sclerosis and future directions.

Nermin Diab1, Paul M Hassoun2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28495698     DOI: 10.1183/13993003.00522-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

1.  New risk model is able to identify patients with a low risk of progression in systemic sclerosis.

Authors:  Nina Marijn van Leeuwen; Marc Maurits; Sophie Liem; Jacopo Ciaffi; Nina Ajmone Marsan; Maarten Ninaber; Cornelia Allaart; Henrike Gillet van Dongen; Robbert Goekoop; Tom Huizinga; Rachel Knevel; Jeska De Vries-Bouwstra
Journal:  RMD Open       Date:  2021-05

2.  Therapeutic inhibition of HIF-2α reverses polycythemia and pulmonary hypertension in murine models of human diseases.

Authors:  Manik C Ghosh; De-Liang Zhang; Wade H Ollivierre; Audrey Noguchi; Danielle A Springer; W Marston Linehan; Tracey A Rouault
Journal:  Blood       Date:  2021-05-06       Impact factor: 25.476

Review 3.  The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review.

Authors:  Francesco Bonomi; Silvia Peretti; Gemma Lepri; Vincenzo Venerito; Edda Russo; Cosimo Bruni; Florenzo Iannone; Sabina Tangaro; Amedeo Amedei; Serena Guiducci; Marco Matucci Cerinic; Silvia Bellando Randone
Journal:  J Pers Med       Date:  2022-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.